Cell-free DNA screening for rare autosomal trisomies and segmental chromosome imbalances

Yvette C. Raymond, Shavi Fernando, Melody Menezes, Simon Meagher, Ben W. Mol, Andrew McLennan, Fergus Scott, Karen Mizia, Karen Carey, Gabrielle Fleming, Daniel Lorber Rolnik

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Abstract

Objective: To assess the outcomes of pregnancies at high-risk for rare autosomal trisomies (RATs) and segmental imbalances (SIs) on cell-free DNA (cfDNA) screening. Method: A retrospective study of women who underwent cfDNA screening between September 2019 and July 2021 at three ultrasound services in Australia. Positive predictive values (PPVs) were calculated using fetal chromosomal analysis. Results: Among 23,857 women screened, there were 93 high-risk results for RATs (0.39%) and 82 for SIs (0.34%). The PPVs were 3.8% (3/78, 95% CI 0.8%–10.8%) for RATs and 19.1% (13/68, 95% CI 10.6%–30.5%) for SIs. If fetuses with structural anomalies were also counted as true-positive cases, the PPV for RATS increased to 8.5% (7/82, 95% CI 3.5%–16.8%). Among 85 discordant cases with birth outcomes available (65.4%), discordant positive RATs had a significantly higher proportion of infants born below the 10th and 3rd birthweight percentiles than expected (19.6% (p = 0.022) and 9.8% (p = 0.004), respectively), which was not observed in the SI group (2.9% < 10th (p = 0.168) and 0.0% <3rd (p = 0.305)). Conclusion: The PPVs for SI and RAT results are low, except when a structural abnormality is also present. Discordant positive RATs are associated with growth restriction.

Original languageEnglish
Pages (from-to)1349-1357
Number of pages9
JournalPrenatal Diagnosis
Volume42
Issue number11
DOIs
Publication statusPublished - Oct 2022

Cite this